As of Nov 27
| +0.03 / +0.13%|
The 7 analysts offering 12-month price forecasts for BioMed Realty Trust Inc have a median target of 23.75, with a high estimate of 24.00 and a low estimate of 20.00. The median estimate represents a +1.28% increase from the last price of 23.45.
The current consensus among 9 polled investment analysts is to Hold stock in BioMed Realty Trust Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.